Literature DB >> 26068727

Neurobiological Interactions Between Stress and the Endocannabinoid System.

Maria Morena1,2, Sachin Patel3, Jaideep S Bains1,4, Matthew N Hill1,2,5.   

Abstract

Stress affects a constellation of physiological systems in the body and evokes a rapid shift in many neurobehavioral processes. A growing body of work indicates that the endocannabinoid (eCB) system is an integral regulator of the stress response. In the current review, we discuss the evidence to date that demonstrates stress-induced regulation of eCB signaling and the consequential role changes in eCB signaling have with respect to many of the effects of stress. Across a wide array of stress paradigms, studies have generally shown that stress evokes bidirectional changes in the two eCB molecules, anandamide (AEA) and 2-arachidonoyl glycerol (2-AG), with stress exposure reducing AEA levels and increasing 2-AG levels. Additionally, in almost every brain region examined, exposure to chronic stress reliably causes a downregulation or loss of cannabinoid type 1 (CB1) receptors. With respect to the functional role of changes in eCB signaling during stress, studies have demonstrated that the decline in AEA appears to contribute to the manifestation of the stress response, including activation of the hypothalamic-pituitary-adrenal (HPA) axis and increases in anxiety behavior, while the increased 2-AG signaling contributes to termination and adaptation of the HPA axis, as well as potentially contributing to changes in pain perception, memory and synaptic plasticity. More so, translational studies have shown that eCB signaling in humans regulates many of the same domains and appears to be a critical component of stress regulation, and impairments in this system may be involved in the vulnerability to stress-related psychiatric conditions, such as depression and posttraumatic stress disorder. Collectively, these data create a compelling argument that eCB signaling is an important regulatory system in the brain that largely functions to buffer against many of the effects of stress and that dynamic changes in this system contribute to different aspects of the stress response.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26068727      PMCID: PMC4677118          DOI: 10.1038/npp.2015.166

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  274 in total

1.  Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala.

Authors:  Matthew N Hill; W-S Vanessa Ho; Sarah E Meier; Boris B Gorzalka; Cecilia J Hillard
Journal:  Eur J Pharmacol       Date:  2005-12-01       Impact factor: 4.432

Review 2.  Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation.

Authors:  Sachin Patel; Cecilia J Hillard
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

3.  Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade.

Authors:  Luigi Bellocchio; Edgar Soria-Gómez; Carmelo Quarta; Mathilde Metna-Laurent; Pierre Cardinal; Elke Binder; Astrid Cannich; Anna Delamarre; Martin Häring; Mar Martín-Fontecha; David Vega; Thierry Leste-Lasserre; Dusan Bartsch; Krisztina Monory; Beat Lutz; Francis Chaouloff; Uberto Pagotto; Manuel Guzman; Daniela Cota; Giovanni Marsicano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

Review 4.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

5.  The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.

Authors:  W M Olango; M Roche; G K Ford; B Harhen; D P Finn
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

6.  The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis.

Authors:  Andrea Navarria; Alessandra Tamburella; Fabio A Iannotti; Vincenzo Micale; Giovanni Camillieri; Lucia Gozzo; Roberta Verde; Roberta Imperatore; Gian Marco Leggio; Filippo Drago; Vincenzo Di Marzo
Journal:  Pharmacol Res       Date:  2014-05-23       Impact factor: 7.658

7.  Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.

Authors:  Jamie Horder; Michael Browning; Martina Di Simplicio; Philip J Cowen; Catherine J Harmer
Journal:  J Psychopharmacol       Date:  2011-03-15       Impact factor: 4.153

8.  A comparison of two repeated restraint stress paradigms on hypothalamic-pituitary-adrenal axis habituation, gonadal status and central neuropeptide expression in adult male rats.

Authors:  M Gray; B Bingham; V Viau
Journal:  J Neuroendocrinol       Date:  2009-12-04       Impact factor: 3.627

9.  Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum.

Authors:  Silvia Rossi; Valentina De Chiara; Alessandra Musella; Hajime Kusayanagi; Giorgia Mataluni; Giorgio Bernardi; Alessandro Usiello; Diego Centonze
Journal:  J Neurosci       Date:  2008-07-16       Impact factor: 6.167

10.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

View more
  158 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

2.  Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.

Authors:  Florence P Varodayan; Michal Bajo; Neeraj Soni; George Luu; Samuel G Madamba; Paul Schweitzer; Marisa Roberto
Journal:  Addict Biol       Date:  2016-01-20       Impact factor: 4.280

3.  Impact of Stress on the Brain: Pathology, Treatment and Prevention.

Authors:  Kerry J Ressler; Jordan W Smoller
Journal:  Neuropsychopharmacology       Date:  2016-01       Impact factor: 7.853

Review 4.  Physiological processes underlying organ injury in alcohol abuse.

Authors:  Flavia M Souza-Smith; Charles H Lang; Laura E Nagy; Shannon M Bailey; Loren H Parsons; Gary J Murray
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

5.  Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence.

Authors:  Samuel W Centanni; Bridget D Morris; Joseph R Luchsinger; Gaurav Bedse; Tracy L Fetterly; Sachin Patel; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-11-02       Impact factor: 7.853

Review 6.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

7.  Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.

Authors:  Gaurav Bedse; Nolan D Hartley; Emily Neale; Andrew D Gaulden; Toni A Patrick; Philip J Kingsley; Md Jashim Uddin; Niels Plath; Lawrence J Marnett; Sachin Patel
Journal:  Biol Psychiatry       Date:  2017-03-15       Impact factor: 13.382

8.  Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat.

Authors:  M D Lange; T Daldrup; F Remmers; H J Szkudlarek; J Lesting; S Guggenhuber; S Ruehle; K Jüngling; T Seidenbecher; B Lutz; H C Pape
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

Review 9.  Meet Your Stress Management Professionals: The Endocannabinoids.

Authors:  Terri A deRoon-Cassini; Todd M Stollenwerk; Margaret Beatka; Cecilia J Hillard
Journal:  Trends Mol Med       Date:  2020-08-28       Impact factor: 11.951

10.  Presynaptic mGluRs Control the Duration of Endocannabinoid-Mediated DSI.

Authors:  Phillip L W Colmers; Jaideep S Bains
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.